Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms

Endocrinology

Volumn 149, Issue 3, 2008, Pages 889-898

  Liu, Dongmin ^a,b,e   Iruthayanathan, Mary ^a,b   Homan, Laurie L ^a,b   Wang, Yiqiang ^c   Yang, Lingling ^c   Wang, Yao ^c   Dillon, Joseph S ^a,b,d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c SHANDONG EYE INSTITUTE   (China)

^d Division of Pediatric Cardiology   (United States)

^e VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PERTUSSIS TOXIN; PRASTERONE;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; FETUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; AORTA; CATTLE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DEHYDROEPIANDROSTERONE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

EID: 40849145707     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1125     Document Type: Article

References (93)

1. Barrett-Connor E, Goodman-Gruen D 1995 The epidemiology of DHEAS and cardiovascular disease. Ann NY Acad Sci 774:259-270
2. Alexandersen P, Haarbo J, Christiansen C 1996 The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 125:1-13
3. Arad Y, Badimon JJ, Badimon L, Hembree WC, Ginsberg HN 1989 Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit. Arteriosclerosis 9:159-166
4. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C 1999 Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84:813-819
5. Lohman R, Yowell R, Barton S, Araneo B, Siemionow M 1997 Dehydroepiandrosterone protects muscle flap microcirculatory hemodynamics from ischemia/reperfusion injury: an experimental in vivo study. J Trauma 42:74-80
6. Eich DM, Nestler JE, Johnson DE, Dworkin GH, Ko D, Wechsler AS, Hess ML 1993 Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation 87:261-269
7. Bednarek-Tupikowska G, Milewicz A, Kossowska B, Bohdanowicz-Pawlak A, Sciborski R 1995 The influence of DHEA on serum lipids, insulin and sex hormone levels in rabbits with induced hypercholesterolemia. Gynecol Endocrinol 9:23-28
8. Kurzman ID, Panciera DL, Miller JB, MacEwen EG 1998 The effect of dehydroepiandrosterone combined with a low-fat diet in spontaneously obese dogs: a clinical trial. Obes Res 6:20-28
9. Haffa AL, MacEwen EG, Kurzman ID, Kemnitz JW 1994 Hypocholesterolemic effect of exogenous dehydroepiandrosterone administration in the rhesus monkey. In Vivo 8:993-997
10. Christopher-Hennings J, Kurzman ID, Haffa AL, Kemnitz JW, MacEwen EG 1995 The effect of high fat diet and dehydroepiandrosterone (DHEA) administration in the rhesus monkey. In Vivo 9:415-420
11. Yorek M, Coppey L, Gellett J, Davidson E, Bing X, Lund D, Dillon J 2002 Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am J Physiol 283:E1067-E1075
12. Bonnet S, Dumas-de-La-Roque E, Begueret H, Marthan R, Fayon M, Dos Santos P, Savineau JP, Baulieu EE 2003 Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension. Proc Natl Acad Sci USA 100:9488-9493
13. Barbagallo M, Shan J, Pang PK, Resnick LM 1995 Effects of dehydroepiandrosterone sulfate on cellular calcium responsiveness and vascular contractility. Hypertension 26:1065-1069
14. Mohan PF, Benghuzzi H 1997 Effect of dehydroepiandrosterone on endothelial cell proliferation. Biomed Sci Instrum 33:550-555
15. Yoneyama A, Kamiya Y, Kawaguchi M, Fujinami T 1997 Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells. Life Sci 60:833-838
16. Khalil A, Lehoux JG, Wagner RJ, Lesur O, Cruz S, Dupont E, Jay-Gerin JP, Wallach J, Fulop T 1998 Dehydroepiandrosterone protects low density lipoproteins against peroxidation by free radicals produced by γ-radiolysis of ethanol-water mixtures. Atherosclerosis 136:99-107
17. Mohan PF, Jacobson MS 1993 Inhibition of macrophage superoxide generation by dehydroepiandrosterone. Am J Med Sci 306:10-15
18. Taniguchi S, Yanase T, Kobayashi K, Takayanagi R, Nawata H 1996 Dehydroepiandrosterone markedly inhibits the accumulation of cholesteryl ester in mouse macrophage J774-1 cells. Atherosclerosis 126:143-154
19. Herrington DM 1995 Dehydroepiandrosterone and coronary atherosclerosis. Ann NY Acad Sci 774:271-280
20. Mortola JF, Yen SS 1990 The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 71:696-704
21. Beer NA, Jakubowicz DJ, Matt DW, Beer RM, Nestler JE 1996 Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men. Am J Med Sci 311:205-210
22. Jesse RL, Loesser K, Eich DM, Qian YZ, Hess ML, Nestler JE 1995 Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. Ann NY Acad Sci 774:281-290
23. Lasco A, Frisina N, Morabito N, Gaudio A, Morini E, Trifiletti A, Basile G, Nicita-Mauro V, Cucinotta D 2001 Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. Eur J Endocrinol 145:457-461
24. Kawano H, Yasue H, Kitagawa A, Hirai N, Yoshida T, Soejima H, Miyamoto S, Nakano M, Ogawa H 2003 Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. J Clin Endocrinol Metab 88:3190-3195
25. Williams MR, Dawood T, Ling S, Dai A, Lew R, Myles K, Funder JW, Sudhir K, Komesaroff PA 2004 Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J Clin Endocrinol Metab 89:4708-4715
26. Hayashi T, Esaki T, Muto E, Kano H, Asai Y, Thakur NK, Sumi D, Jayachandran M, Iguchi A 2000 Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide. Arterioscler Thromb Vasc Biol 20:782-792
27. Williams MR, Ling S, Dawood T, Hashimura K, Dai A, Li H, Liu JP, Funder JW, Sudhir K, Komesaroff PA 2002 Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab 87:176-181
28. Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR 2003 Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinol 144:3449-3455
29. Liu D, Dillon JS 2002 Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to G+(i2,3). J Biol Chem 277:21379-21388
30. Liu D, Dillon JS 2004 Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids 69:279-289
31. Formoso G, Chen H, Kim J, Montagnani M, Consoli A, Quon M 2006 Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase-and mitogen-activated protein kinase-dependent pathways in vascular endothelium. Mol Endocrinol 20:1153-1163
32. Charalampopoulos I, Alexaki V, Lazaridis I, Dermitzaki E, Avlonitis N, Tsatsanis C, Calogeropoulou T, Margioris A, Castanas E, Gravanis A 2006 G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB J 20:577-579
33. Matsumoto T, Turesson I, Book M, Gerwins P, Claesson-Welsh L 2002 p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. J Cell Biol 156:149-160
34. Pintucci G, Moscatelli D, Saponara F, Biernacki P, Baumann F, Bizekis C, Galloway A, Basilico C, Mignatti P 2002 Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J 16:598-600
35. Liu D, Homan L, Dillon J 2004 Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5′-monophosphate-dependent mechanism. Endocrinol 145:5532-5539
36. Wang F, Van Brocklyn J, Hobson J, Movafagh S, Zukowska-Grojec Z, Milstien S, Spiegel S 1999 Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem 274:35343-35350
37. Lee H, Goetzl E, An S 2000 Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am J Physiol 278:C612-C618
38. Lee M, Moon E, Lee S, Kim M, Kim K, Kim Y 2001 Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Cancer Res 61:3290-3293
39. Tang H, Hao Q, Fitzgerald T, Sasaki T, Landon E, Inagami T 2002 Pyk2/CAKbeta tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells. J Biol Chem 277:5441-5447
40. Liu F, Austin D, Mellon P, Olefsky J, Webster N 2002 GnRH activates ERK1/2 leading to the induction of c-fos and LHβ protein expression in LβT2 cells. Mol Endocrinol 16:419-434
41. Kimura T, Watanabe T, Sato K, Kon J, Tomura H, Tamama K, Kuwabara A, Kanda T, Kobayashi I, Ohta H, Ui M, Okajima F 2000 Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem J 1:71-76
42. Wu L, Mayo L, Dunbar J, Kessler K, Baerwald M, Jaffe E, Wang D, Warren R, Donner D 2000 Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 275:5096-5103
43. Pedram A, Razandi M, Levin ER 1998 Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 273:26722-26728
44. Liu D, Si H, Reynolds K, Zhen W, Jia Z, Dillon J 2007 Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Gαi-protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of anti-apoptotic Bcl-2 expression. Endocrinology 48:3068-3076
45. Shizukuda Y, Tang S, Yokota R, Ware J 1999 Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cδ activity Circ Res 85:247-256
46. Razandi M, Pedram A, Park ST, Levin ER 2003 Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278:2701-2712
47. Machelon V, Nome F, Tesarik J 1998 Nongenomic effects of androstenedione on human granulosa luteinizing cells. J Clin Endocrinol Metab 83:263-269
48. Qiu J, Lou L, Huang X, Lou S, Pei G, Chen J 1998 Nongenomic mechanisms of glucocorticoid inhibition of nicotine-induced calcium influx in PC12 cells: involvement of protein kinase C. Endocrinology 139:5103-5108
49. Peter W, Benten M, Lieberherr M, Sekeris C, Wunderlich F 1997 Testosterone induces Ca2+ influx via non-genomic surface receptors in activated T cells. FEBS Lett 407:211-214
50. Peter W, Benten M, Lieberherr M, Giese G, Sekeris C, Wunderlich F 1998 Estradiol binding to cell surface raises cytosolic free calcium in T cells. FEBS Lett 422:349-353
51. Stefano G, Cadet P, Breton C, Goumon Y, Prevot V, Dessaint J 2000 Estradiol-stimulated nitric oxide release in human granulocytes is dependent on intracellular calcium transients: evidence of a cell surface estrogen receptor. Blood 95:3951-3958
52. Stevis PE, Deecher DC, Suhadolnik L, Mallis LM, Frail DE 1999 Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 140:5455-5458
53. Liu D, Ren M, Dillon J 2006 Dehydroepiandrosterone inhibits agonist-induced intracellular calcium release in INS-1 cells by a non-genomic mechanism. Steroids 71:691-699
54. Mattingly R, Macara I 1996 Phosphorylation-dependent activation of the Ras-GRF/CDC25Mm exchange factor by muscarinic receptors and G-protein β/γ subunits. Nature 382:268-272
55. Jo H, Sipos K, Go Y, Law R, Rong J, McDonald J 1997 Differential effect of shear stress on extracellular signal-regulated kinase and N-terminal Jun kinase in endothelial cells. Gi2- and Gβ/γ-dependent signaling pathways. J Biol Chem 272:1395-1401
56. Jones S, Kazlauskas A 2001 Growth-factor-dependent mitogenesis requires two distinct phases of signaling. Nat Cell Biol 3:165-172
57. Otto A 1995 A one minute pulse of estradiol to MCF-7 breast cancer cells changes estrogen receptor binding properties and commits cells to induce estrogenic responses. J Steroid Biochem Mol Biol 54:39-46
58. Wong J, Le H, Zsarnovszky A, Belcher S 2003 Estrogens and ICI182,780 (Faslodex) modulate mitosis and cell death in immature cerebellar neurons via rapid activation of p44/p42 mitogen-activated protein kinase. J Neurosci 23:4984-4995
59. Frodin M, Gammeltoft S 1999 Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151:65-77
60. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouyssagur J 1999 Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 18:664-674
61. Babu G, Lalli M, Sussman M, Sadoshima J, Periasamy M 2000 Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy. J Mol Cell Cardiol 32:1447-1457
62. Vanhoutte P, Barnier J, Guibert B, Pages C, Besson M, Hipskind R, Caboche J 1999 Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol Cell Biol 19:136-146
63. Hodge C, Liao J, Stofega M, Guan K, Carter-Su C, Schwartz J 1998 Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J Biol Chem 273:31327-31336
64. El-Dahr S, Dipp S, Baricos W 1998 Bradykinin stimulates the ERK→ Elk-1→ Fos/AP-1 pathway in mesangial cells. Am J Physiol 275:F343-F352
65. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW 1997 Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol 273:L119-L126
66. Caulin-Glaser T, Garcia-Cardena G, Sarrel P, Sessa WC, Bender JR 1997 17β-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circ Res 81:885-892
67. Chen F, Watson CS, Gametchu B 1999 Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells. J Cell Biochem 74:418-429
68. Kim H, Lee J, Jeong J, Bae S, Lee H, Jo I 1999 Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae. Biochem Biophys Res Commun 263:257-262
69. Shaul PW 1999 Rapid activation of endothelial nitric oxide synthase by estrogen. Steroids 64:28-34
70. Peter W, Benten M, Lieberherr M, Giese G, Wrehlke C, Stamm O, Sekeris C, Mossmann H, Wunderlich F 1999 Functional testosterone receptors in plasma membranes of T cells. FASEB J 13:123-133
71. Simoncini T, Genazzani A, Fornari L, Mannella P, Varone G, Caruso A, Liao J 2003 Non-genomic actions of sex steroid hormones. Eur J Endocrinol 148:281-292
72. Norman A, Mizwicki M, Norman D 2004 Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3:27-41
73. Labrie F, Belanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez JL, Candas B 1998 DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 63:322-328
74. Charalampopoulos I, Tsatsanis C, Dermitzaki E, Alexaki VI, Castanas E, Margioris AN, Gravanis A 2004 Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc Natl Acad Sci USA 101:8209-8214
75. Sicard F, Krug A, Ziegler C, Sperber S, Ehrhart-Bornstein M, Bornstein S 2006 Role of DHEA and growth factors in chromaffin cell proliferation. Ann NY Acad Sci 1073:312-316
76. Sakakura Y, Nakagawa Y, Ohzeki T 2006 Differential effect of DHEA on mitogen-induced proliferation of T and B lymphocytes. J Steroid Biochem Mol Biol 99:115-120
77. Banerjee S, Campbell D, Weston A, Banerjee D 1997 Biphasic estrogen response on bovine adrenal medulla capillary endothelial cell adhesion, proliferation and tube formation. Mol Cell Biochem 177:97-105
78. Varet J, Vincent L, Akwa Y, Mirshahi P, Lahary A, Legrand E, Opolon P, Mishal Z, Baulieu EE, Soria J, Soria C, Li H 2004 Dose-dependent effect of dehydroepiandrosterone, but not of its sulphate ester, on angiogenesis. Eur J Pharmacol 502:21-30
79. Zapata E, Ventura JL, De la Cruz K, Rodriguez E, Damian P, Masso F, Montano LF, Lopez-Marure R 2005 Dehydroepiandrosterone inhibits the proliferation of human umbilical vein endothelial cells by enhancing the expression of p53 and p21, restricting the phosphorylation of retinoblastoma protein, and is androgen- and estrogen-receptor independent. FEBS J 272:1343-1353
80. Coulet F, Nadaud S, Agrapart M, Soubrier F 2003 Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 278:46230-46240
81. Frick M, Dulak J, Cisowski J, Jozkowicz A, Zwick R, Alber H, Dichtl W, Schwarzacher S, Pachinger O, Weidinger F 2003 Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells. Atherosclerosis 170:229-236
82. van der Schaft D, Seftor R, Seftor E, Hess A, Gruman L, Kirschmann D, Yokoyama Y, Griffioen A, MJ H 2004 Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst 96:1473-1477
83. Obrig T, Louise C, Lingwood C, Boyd B, Barley-Maloney L, Daniel T 1993 Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268:15484-15488
84. Bouchet D, Tesson L, Menoret S, Charreau B, Mathieu P, Yagita H, Duisit G, Anegon I 2002 Differential sensitivity of endothelial cells of various species to apoptosis induced by gene transfer of Fas ligand: role of FLIP levels. Mol Med 8:612-623
85. Lai GJ, McCobb DP 2002 Opposing actions of adrenal androgens and glucocorticoids on alternative splicing of Slo potassium channels in bovine chromaffin cells. Proc Natl Acad Sci USA 99:7722-7727
86. Geraldes P, Sirois MG, Bernatchez P, Tanguay J 2002 Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase. Arterioscler Thromb Vasc Biol 22:1585-1590
87. Ling S, Dai A, Williams MR, Myles K, Dilley RJ, Komesaroff PA, Sudhir K 2002 Testosterone (T) enhances apoptosis-related damage in human vascular endothelial cells. Endocrinology 143:1119-1125
88. Rubio-Gayosso I, Garcia-Ramirez O, Gutierrez-Serdan R, Guevara-Balcazar G, Munoz-Garcia O, Morato-Cartajena T, Zamora-Garza M, Ceballos-Reyes G 2002 Testosterone inhibits bradykinin-induced intracellular calcium kinetics in rat aortic endothelial cells in culture. Steroids 67:393-397
89. Marwah A, Marwah P, Lardy H 2002 Ergosteroids-VI. Metabolism of dehydroepiandrosterone by rat liver in vitro: a liquid chromatographic-mass spectrometric study. J Chromatogr B 767:285-299
90. Shi J, Schulze S, Lardy HA 2000 The effect of 7-oxo-DHEA acetate on memory in young and old C57BL/6 mice. Steroids 65:124-129
91. Padgett DA, Loria RM, Sheridan JF 1997 Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol. J Neuroimmunol 78:203-211
92. Hinson JP, Khan M 2004 Dehydroepiandrosterone sulphate (DHEAS) inhibits growth of human vascular endothelial cells. Endocr Res 30:667-671
93. Hinson J, Renshaw D, Vakharia K, King P, Dehydroepiandrosterone sulphate (DHEAS) inhibits growth of human vascular endothelial cells. Program of the 86th Annual Meeting of The Endocrine Society, New Orleans, LA, 2004, p 186 (Abstract P1-132)